{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:07:21Z","timestamp":1778623641042,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pericarditis, along with myocarditis, is being increasingly reported after the coronavirus disease 2019 (COVID-19) vaccine, but the best treatment strategy in this specific setting is still unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We report a case of acute pericarditis after the second dose of mRNA COVID-19 vaccine with recurrence of large pericardial effusion after a previous pericardiocentesis and anti-inflammatory drugs tapering. The patient was successfully treated with the recombinant interleukin-1 receptor antagonist anakinra, with full reabsorption of the pericardial effusion and an abrupt drop of the inflammatory markers within 72\u2005h. The patient was discharged a few days later, with a further decrease of the inflammatory markers and no residual symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Anakinra is being increasingly used in the treatment of recurrent pericarditis due to its capability to interrupt the autoinflammatory response leading to deleterious cytokine storms. On account of its high efficacy and rapid onset, it has been reported to rapidly reverse large inflammatory pericardial effusions. Pericarditis and myocarditis have been reported after the COVID-19 vaccine, but this is the first case of COVID-19 vaccine-related pericarditis and pericardial effusion successfully treated with anakinra, avoiding a second pericardiocentesis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytac123","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:50:46Z","timestamp":1647607846000},"source":"Crossref","is-referenced-by-count":9,"title":["Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-9492","authenticated-orcid":false,"given":"Francesco","family":"Perna","sequence":"first","affiliation":[{"name":"Cardiac Arrhythmia Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-2110","authenticated-orcid":false,"given":"Elena","family":"Verecchia","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy"},{"name":"Periodic Fevers Research Center, Catholic University of the Sacred Heart , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-1682","authenticated-orcid":false,"given":"Gaetano","family":"Pinnacchio","sequence":"additional","affiliation":[{"name":"Cardiac Arrhythmia Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-5788","authenticated-orcid":false,"given":"Laura","family":"Gerardino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy"},{"name":"Periodic Fevers Research Center, Catholic University of the Sacred Heart , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5600","authenticated-orcid":false,"given":"Antonio","family":"Brucato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Azienda Socio Sanitaria Territoriale (ASST) Fatebenefratelli-Sacco and Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan , Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1560-3907","authenticated-orcid":false,"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome, Italy"},{"name":"Periodic Fevers Research Center, Catholic University of the Sacred Heart , Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"2024051617591909100_ytac123-B1","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC)endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"2024051617591909100_ytac123-B2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487319879534","article-title":"Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study","volume":"27","author":"Imazio","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2024051617591909100_ytac123-B3","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1016\/j.vaccine.2021.09.078","article-title":"A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States","volume":"39","author":"Lazaros","year":"2021","journal-title":"Vaccine"},{"key":"2024051617591909100_ytac123-B4","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"2024051617591909100_ytac123-B5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005121.pub3","article-title":"Anakinra for rheumatoid arthritis","author":"Mertens","year":"2009  21;(1)","journal-title":"Cochrane Database Syst Rev."},{"key":"2024051617591909100_ytac123-B6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, doubleblind, placebo-controlled, multicenter trial","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"2024051617591909100_ytac123-B7","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","article-title":"Targeting interleukin-1 in heart disease","volume":"128","author":"Van Tassell","year":"2013","journal-title":"Circulation"},{"key":"2024051617591909100_ytac123-B8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s11739-020-02627-2","article-title":"Early introduction of anakinra improves acute pericarditis and prevents tamponade in Staphylococcal sepsis","volume":"16","author":"Sicignano","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2024051617591909100_ytac123-B9","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fimmu.2018.01233","article-title":"Treating heart inflammation with Interleukin-1 blockade in a case of Erdheim\u2013Chester disease","volume":"9","author":"Tomelleri","year":"2018","journal-title":"Front Immunol"},{"key":"2024051617591909100_ytac123-B10","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2024051617591909100_ytac123-B11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2024051617591909100_ytac123-B12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.cjco.2020.10.003","article-title":"Rapid response to cytokine storm inhibition using anakinra in a patient with COVID-19 myocarditis","volume":"3","author":"Trpkov","year":"2021","journal-title":"CJC Open"},{"key":"2024051617591909100_ytac123-B13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/vaccines9101186","article-title":"Shedding the light on post-vaccine myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients","volume":"9","author":"Hajjo","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024051617591909100_ytac123-B14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"2024051617591909100_ytac123-B15","author":"Government of Israel, Ministry of Health"},{"key":"2024051617591909100_ytac123-B16","article-title":"Coronavirus vaccine-weekly summary of Yellow Card reporting [Internet]","author":"Medicines and. Healthcare Products Regulatory Agency (MHRA)"},{"key":"2024051617591909100_ytac123-B17","author":"European Medicines Agency Pharmacovigilance Risk Assessment Committee"},{"key":"2024051617591909100_ytac123-B18","author":"Center for Disease Control. United States of America Department of Health and Human Services."},{"key":"2024051617591909100_ytac123-B19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military","volume":"6","author":"Montgomery","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2024051617591909100_ytac123-B20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hlc.2021.07.011","article-title":"Pericarditis and Cardiomyopathy after COVID-19 vaccination","volume":"30","author":"Pepe","year":"2021","journal-title":"Heart Lung Circ"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytac123\/42952580\/ytac123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/6\/4\/ytac123\/57708036\/ytac123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/6\/4\/ytac123\/57708036\/ytac123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T18:02:48Z","timestamp":1715882568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytac123\/6550505"}},"subtitle":[],"editor":[{"given":"Elad","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Rita","family":"Pavisini","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Reshma","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Katharine","family":"Kott","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytac123","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2022,3,18]]},"article-number":"ytac123"}}